MedTrace Logo

Improving Diagnosis and Treatment of Metastatic Advanced Prostate Cancer

NCT04984395 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-07-30

No results posted yet for this study

Summary

The aim of this study is to provide clinical evidence to determine if Whole Body Magnetic Resonance Imaging (WBMRI) with a novel technique called diffusion-weighted imaging (DWI) can improve current treatment for APC patients, allowing for early identification of disease progression or treatment response, hence facilitating clinical decision-making and leading to improvement in patient care. The IDT study includes two retrospective analyses and a single centre prospective observational study for APC patients.

Conditions

  • Advanced Prostate Carcinoma

Interventions

DIAGNOSTIC_TEST

Post-treatment CT-guided bone marrow biopsy

At post-treatment, 12 +/- 3 weeks after initiating treatment, patients will undergo a CT guided bone marrow biopsy of the same lesion as baseline.

Sponsors & Collaborators

  • Royal Marsden NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Nina Tunariu · The Royal Marsden NHS FT

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-30
Primary Completion
2024-05-31
Completion
2024-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04984395 on ClinicalTrials.gov